Skip to content

Research paper

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Journal of the National Cancer Institute
Q1
Mar 2007
Citations: 175
Influential: 6
Observational Studies (Human)
83

Study answer

What this study found

Higher total plant lignans and enterolignans were associated with lower risk of postmenopausal breast cancer, particularly for ER+/PR+ tumors. For ER+/PR+ cancers, the highest vs lowest quartile of total plant lignans yielded RR 0.72 (95% CI 0.58–0.88); total enterolignans RR 0.77 (95% CI 0.62–0.95). Lariciresinol showed a significant inverse association with ER+/PR+ cancer (RR 0.82; 95% CI 0.71–0.95). No clear associations with ER−/PR+, ER+/PR−, or ER−/PR− cancers. Conclusion: In Western populations with low soy intake, higher dietary lignan intake may modestly reduce risk of postmenopausal…

Study & population
Prospective cohort (E3N) of 58,049 postmenopausal French women, aged 41–72 at baseline; observational design; dietary lignan and enterolignan intakes estimated from a validated self-administered diet history questionnaire; outcome: incident primary invasive breast cancer; analyses used multivariable Cox proportional hazards models with stratification by…
Key limitation
Potential exposure misclassification from self-reported diet; residual confounding; incomplete receptor-status data (~20% without ER/PR status); cohort is selected and highly educated, limiting generalizability; enterolignan exposure estimated indirectly and may not capture individual gut microbiota variation.
View sourceOpen PDF

Original abstract

BACKGROUND Studies conducted in Asian populations have suggested that high consumption of soy-based foods that are rich in isoflavone phytoestrogens is associated with a reduced risk of breast cancer. However, the potential associations of other diet…